norverapamil has been researched along with Angor Pectoris in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frishman, W; Hillis, LD; Johnson, SM; Kates, R; Kirsten, E; Klein, M; Packer, M; Pine, M | 1 |
| Lopez, LL; Mehta, J; Pieper, JA; Tartaglione, TA | 1 |
| Frick, MH; Heikkilä, J; Lukkala, K; Pellinen, TJ; Sundberg, S | 1 |
| Hansen, JF; Jespersen, CM; Klitgaard, NA; Nielsen, H | 1 |
| Anderson, P | 1 |
| Lennard, MS; McCourty, JC; Silas, JH; Tucker, GT | 1 |
| Elliott, SL; Horowitz, JD; Powell, AC | 1 |
| Piotrovskiĭ, VK; Riabokon', OS; Rumiantsev, DO; Slastnikova, ID; Vygodin, VA | 1 |
| Metelitsa, VI; Nikolenko, SA; Piotrovskii, VK; Riabokon, OS; Rumiantsev, DO | 1 |
1 review(s) available for norverapamil and Angor Pectoris
| Article | Year |
|---|---|
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; Clinical Trials as Topic; Female; Humans; Hypertension; Injections, Intravenous; Kinetics; Liver Cirrhosis; Male; Middle Aged; Nifedipine; Verapamil | 1986 |
4 trial(s) available for norverapamil and Angor Pectoris
| Article | Year |
|---|---|
Clinical relevance of verapamil plasma levels in stable angina pectoris.
Topics: Administration, Oral; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Heart Conduction System; Humans; Kinetics; Male; Middle Aged; Physical Exertion; Verapamil | 1982 |
Efficacy of conventional and sustained-release verapamil in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Blood Pressure; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Verapamil | 1992 |
Sustained-release and instant-release verapamil in treatment of angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Verapamil | 1989 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; Clinical Trials as Topic; Female; Humans; Hypertension; Injections, Intravenous; Kinetics; Liver Cirrhosis; Male; Middle Aged; Nifedipine; Verapamil | 1986 |
5 other study(ies) available for norverapamil and Angor Pectoris
| Article | Year |
|---|---|
Pharmacokinetics of verapamil and norverapamil during long-term oral therapy.
Topics: Aged; Angina Pectoris; Biotransformation; Humans; Kinetics; Male; Middle Aged; Time Factors; Verapamil | 1983 |
The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Propranolol; Verapamil | 1988 |
Verapamil in unstable angina pectoris: failure to demonstrate a relationship between efficacy and plasma levels.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Female; Humans; Male; Middle Aged; Rest; Verapamil | 1988 |
[Dynamics of the anti-anginal effect and of the concentrations of verapamil and its metabolites in the blood serum of patients with stenocardia of exertion].
Topics: Adult; Angina Pectoris; Dose-Response Relationship, Drug; Exercise Test; Humans; Male; Middle Aged; Physical Exertion; Time Factors; Verapamil | 1986 |
Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Biological Availability; Half-Life; Humans; Kinetics; Male; Middle Aged; Nitriles; Regression Analysis; Verapamil | 1986 |